Bombesin, antagonists & inhibitors
- Name
- Bombesin, antagonists & inhibitors
- Accession Number
- DBCAT004885
- Description
Not Available
- Drugs
Drug Drug Description Bombesin Bombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and... - Drugs & Drug Targets
Drug Target Type